34881-45-3

Basic information

• Product Name: 1-bromo-2-isopropyl-4-methoxybenzene
• Synonyms: 1-bromo-2-isopropyl-4-methoxybenzene;4-Bromo-3-isopropylanisole
• CAS NO: 34881-45-3
• Molecular Formula: C₁₀H₁₃BrO
• Molecular Weight: 229.11362
• Mol File: 34881-45-3.mol
• Article Data: 13

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 1-bromo-2-isopropyl-4-methoxybenzene(CAS DataBase Reference)
• NIST Chemistry Reference: 1-bromo-2-isopropyl-4-methoxybenzene(34881-45-3)
• EPA Substance Registry System: 1-bromo-2-isopropyl-4-methoxybenzene(34881-45-3)

Safety Data

• Hazardous Substances Data: 34881-45-3(Hazardous Substances Data)

Usage

General Description

1-bromo-2-isopropyl-4-methoxybenzene, also known as 1-bromo-2-(1-methylethyl)-4-methoxybenzene, is a chemical compound with the molecular formula C10H13BrO. It is a colorless to light yellow liquid with a strong, sweet odor. This chemical is commonly used as an intermediate in the production of pharmaceuticals, fragrances, and other organic compounds. It is also employed as a reagent in organic synthesis and is known for its mild, selective bromination properties. Additionally, 1-bromo-2-isopropyl-4-methoxybenzene is used in the manufacturing of dyes and pigments, as well as in the production of plastics and polymers. Due to its versatile applications, this compound is considered an important building block in the chemical industry. However, it is important to handle this chemical with caution and adhere to proper safety measures, as it may pose health and environmental risks if not properly managed.

Upstream product

• 6380-20-7 3-isopropylanisole 
• 618-45-1 3-isopropylhydroxybenzene 
• 74-88-4 methyl iodide 
• 853271-15-5 2-(2-bromo-5-methoxyphenyl) propan-2-ol 
• 35450-36-3 methyl 2-bromo-5-methoxybenzoate 
• 16606-28-3 2-bromo-5-isopropyl-phenol 
• 16606-29-4 4-bromo-3-(propan-2-yl)phenol 

Downstream Products

• 849192-02-5 tri-(o-isopropyl-p-methoxyphenyl)phosphine 
• 161480-96-2 2-isopropyl-4-methoxylbenzoic acid 
• 865305-07-3 5-bromo-4-isopropyl-2-methoxy-benzaldehyde 
• 865305-06-2 5-bromo-2-isopropyl-4-methoxy-benzaldehyde 
• 1359976-62-7 (1S)-2,3,4,6-tetra-O-acetyl-1,5-anhydro-1-{5-[(4-bromophenyl)methyl]-2-methoxy-4-(propan-2-yl)phenyl}-D-glucitol 
• 1240305-17-2 (E)-N-(1-((2-(dimethylamino)ethyl)amino)-2-methyl-1-oxopropan-2-yl)-4-(4-(2-isopropyl-4-methoxy-5-((2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)benzyl)phenyl)-2,2-dimethylbut-3-enamide 
• 313667-09-3 4-methoxy-2-isopropylphenylboronic acid 
• 16606-29-4 4-bromo-3-(propan-2-yl)phenol 
• 142577-00-2 N,N-Diethyl-2-isopropyl-4-methoxy-6-sulfamoylbenzamide 
• 157887-45-1 2-Diethylcarbamoyl-3-isopropyl-5-methoxy-benzenesulfonyl chloride 
• 142576-99-6 N,N-Diethyl-2-isopropyl-4-methoxybenzamide 

Relevant articles and documents

Zwitterionic-Salt-Catalyzed Site-Selective Monobromination of Arenes

A zwitterionic-salt-catalyzed electrophilic monobromination of arenes with high regioselectivity has been developed. Under mild reaction conditions, a wide range of monobrominated aromatic compounds can be obtained in excellent yields. The reaction can be operated using an extremely low catalyst loading (0.05 mol %) with the inexpensive brominating agent N-bromosuccinimide. The versatility of this catalytic protocol has been demonstrated by the scale-up reaction with a 0.01 mol % catalyst loading to provide the selectively halogenated compound in quantitative yield.

METHODS AND COMPOSITIONS FOR TREATING DISEASES AND CONDITIONS

Provided herein include methods and compositions for treating diseases or conditions. In some embodiments provided are methods for treating one or more diseases or conditions selected from the group consisting of hypertension, heart failure, dyspnea, and

SUBSTITUTED DIHYDRO AND TETRAHYDRO OXAZOLOPYRIMIDINONES, PREPARATION AND USE THEREOF

The present invention relates to a series of substituted dihydro and tetrahydro oxazolopyrimidinones, specifically, to a series of 2-substituted-2,3-dihydro-oxazolo[3,2-a]pyrimidin-7-ones and 2-substituted-2,3,5,6-tetra-hydro-oxazolo[3,2-a]pyrimidin-7-ones of formula (I): Wherein p, n, X, Y, R1, R2, R3, R4, R5, R6, R7 and R8 are as defined herein. This invention also relates to methods of making these compounds including novel intermediates. The compounds of this invention are modulators of metabotropic glutamate receptors (mGluR), particularly, mGluR2 receptor. Therefore, the compounds of this invention are useful as pharmaceutical agents, especially in the treatment and/or prevention of a variety of central nervous system disorders (CNS), including but not limited to acute and chronic neurodegenerative conditions, psychoses, convulsions, anxiety, depression, migraine, pain, sleep disorders and emesis.